Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Requires Activation of the Sphingosine 1-Phosphate Receptor Subtype 1.
Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Nitrous oxide induced myeloneuropathy: a case report.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Letter to the Editor.
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
Impact of multiple sclerosis relapses on progression diminishes with time.
Early development of anti-natalizumab antibodies in MS patients.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.
Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.
Antidepressant activity of fingolimod in mice.
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.

Pages